<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(3)</volume><submitter>Mastroianno S</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Atherosclerosis is a complex multifactorial disease and the apolipoprotein E (APOE) polymorphism has been associated to vascular complications of atherosclerosis.&lt;h4>Objectives&lt;/h4>To investigate the relationship between the APOE genotypes and advanced peripheral vascular disease.&lt;h4>Materials and methods&lt;/h4>258 consecutive patients (201 males and 57 females, mean age 70.83 ± 7.89 years) with severe PVD were enrolled in a 42-months longitudinal study (mean 31.65 ± 21.11 months) for major adverse cardiovascular events. At follow-up genotypes of the APOE polymorphism were investigated in blinded fashion.&lt;h4>Results&lt;/h4>As compared with ε3/ε3, in ε4-carriers a significant higher incidence of major adverse cardiovascular events (35.58% vs. 20.79%; p = 0.025) and total perip</pubmed_abstract><journal>PloS one</journal><pagination>e0171055</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5332070</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Role of the APOE polymorphism in carotid and lower limb revascularization: A prospective study from Southern Italy.</pubmed_title><pmcid>PMC5332070</pmcid><pubmed_authors>Paroni G</pubmed_authors><pubmed_authors>Di Stolfo G</pubmed_authors><pubmed_authors>Seripa D</pubmed_authors><pubmed_authors>Urbano M</pubmed_authors><pubmed_authors>Greco A</pubmed_authors><pubmed_authors>Gravina C</pubmed_authors><pubmed_authors>d'Arienzo C</pubmed_authors><pubmed_authors>Coli C</pubmed_authors><pubmed_authors>Pacilli MA</pubmed_authors><pubmed_authors>Mastroianno S</pubmed_authors><pubmed_authors>De Luca G</pubmed_authors><pubmed_authors>Russo A</pubmed_authors><pubmed_authors>Potenza DR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Role of the APOE polymorphism in carotid and lower limb revascularization: A prospective study from Southern Italy.</name><description>&lt;h4>Background&lt;/h4>Atherosclerosis is a complex multifactorial disease and the apolipoprotein E (APOE) polymorphism has been associated to vascular complications of atherosclerosis.&lt;h4>Objectives&lt;/h4>To investigate the relationship between the APOE genotypes and advanced peripheral vascular disease.&lt;h4>Materials and methods&lt;/h4>258 consecutive patients (201 males and 57 females, mean age 70.83 ± 7.89 years) with severe PVD were enrolled in a 42-months longitudinal study (mean 31.65 ± 21.11 months) for major adverse cardiovascular events. At follow-up genotypes of the APOE polymorphism were investigated in blinded fashion.&lt;h4>Results&lt;/h4>As compared with ε3/ε3, in ε4-carriers a significant higher incidence of major adverse cardiovascular events (35.58% vs. 20.79%; p = 0.025) and total perip</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017</publication><modification>2025-04-18T23:36:15.737Z</modification><creation>2019-03-26T22:49:19Z</creation></dates><accession>S-EPMC5332070</accession><cross_references><pubmed>28249002</pubmed><doi>10.1371/journal.pone.0171055</doi></cross_references></HashMap>